Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000869471) titled 'A Prospective Investigation on the Safety and Feasibility of Ablation in the Uterus' on Aug. 11.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Ascend Clinical Research Organisation, Pty Ltd.
Condition:
Adenomyosis
Adenomyosis
Reproductive Health and Childbirth - Menstruation and menopause
Intervention:
The purpose of this research study is to assess the safety and feasibility of a new device designed for the ablation of uterine tissue. Subjects will ...